Stories about Forschung
- One documentmore
Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...
moreESSL - European Severe Storms Laboratory
Europe needs Twisters campaign
Wiener Neustadt, Austria (ots) - Researchers from all over Europe are organising high-density measurements of severe storms, similar to the new film Twisters. Severe weather researchers from 14 European countries want to work together to get to the bottom of severe thunderstorms so that they can provide better warnings in future. To this aim, they are currently planning the largest European measurement campaign on severe thunderstorms to date. "We want to use the latest ...
morePress Release: Restless Legs Syndrome: Genetic Discoveries Advance Treatment and Risk Prediction
Researchers at Helmholtz Munich and the Technical University of Munich (TUM) together with international collaborators have conducted the largest genetic investigation of the restless legs syndrome to date. Their findings, ...
moreKontrast Personalberatung GmbH
Postdocs for Core Informatics & PhD Students for Cyber-Physical Systems Wanted
Hamburg (ots) - Karlsruhe Institute of Technology launches two innovative research projects in cooperation with the Helmholtz Association The Karlsruhe Institute of Technology (KIT), one of Europe's leading technical universities, announces the launch of two groundbreaking research projects, which set new standards in basic research on cyber-physical systems and core ...
moreResearchers: The future of democracy is on the ballot in Europe
more
canSERV invites applications for "Revolutionising Cancer Patient Care"
One documentmoreLAST CHANCE: canSERV Second Open Call for Cancer Research Service Provision
One documentmoreBosch Healthcare Solutions GmbH
Bosch and Randox: Strategic partnership brings highly multiplexing PCR to the point of care / BioMEMS technology enables fully automated, simultaneous testing for hundreds of genetic characteristics in just a few minutes
Waiblingen (ots) - - Bosch and Randox Laboratories Ltd. enter partnership for Vivalytic analysis platform to jointly invest around 150 million euros. - First test to feature novel BioMEMS technology will be a highly multiplexing sepsis IVD grade test. Bosch has agreed on a strategic partnership with Randox ...
moreDr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment
moreARTCLINE successfully completes capital increases of EUR 4.4 million
Rostock, Germany (ots) - Today ARTCLINE GmbH announced the successful completion of two further capital increases. In addition to the founders, in particular family offices from Germany participated in the first capital increase of EUR 0.8 million. In addition, a convertible loan from investors was transferred to equity, so that a second capital increase of EUR 3.6 ...
more2022 Marked a Record for German R&D Investments
Berlin (ots) - EUR 121.4 billion was spent in Germany on reasearch and development - more than ever before in a single year. According to the Federal Statistical Office, the amount of money devoted to R&D rose by seven percent in 2022, reaching an all-time high. The figures include commercial, university and non-university research. R&D investments by businesses grew by eight percent, reaching EUR 81.8 billion. That's ...
more
- 4
FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiX
more Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
moreLTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
moreWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
moreUniversità degli studi di Milano - Bicocca
Early Smartphone Use in Children? Two Studies Highlight Long-Term Consequences
Milan (ots) - A group of researchers from the University of Milano-Bicocca and SUPSI, by means of longitudinal data provided by INVALSI (Italian Institute for the Evaluation of the Education System), has confirmed that early smartphone usage before the age of 12 does not bring benefits. Instead, it is associated with lower digital skills, higher problematic smartphone ...
moreThe ocean – a climate champion? How to boost marine carbon dioxide uptake
more
LTS Lohmann Therapie-Systeme AG
LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches
moreRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
moreBirth weight and head circumference predict IQ and motor performance at 4 years of age
moreFraunhofer-Institut für Sichere Informationstechnologie SIT
AI against money laundering
moreThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
moreSwiss Start-Up “Mirai Foods” produces first cultivated tender steak / Breakthrough for Cultivated Premium Beef Steaks
Zurich (ots) - - Three patents for key technologies in “cultivated meat” - Food producer Angst AG takes stake in company - Innovative bioreactor improves efficiency and reduces costs A real new meat experience without sacrifice: Swiss start-up Mirai Foods achieves technological breakthrough for the cultivation ...
more
VectorBuilderille merkittävän innovaatiokilpailun ensimmäinen palkinto
Chicago, IL (ots) - --News Direct-- Maailman johtaviin geeninsiirtoteknologiayhtiöihin lukeutuva VectorBuilder Inc. kertoo Guangzhoussa sijaitsevan tuotekehitys- ja valmistuskeskuksensa voittaneen 7. Kiinan Hangzhoussa järjestetyn Chuangke Innovation and Entrepreneurship Global Competition -innovaatiokilpailun. Tämä arvostettu ja korkeatasoinen kilpailu on Kiinan ...
moreVectorBuilder vann första pris i stor innovationstävling
Chicago, IL (ots) - --News Direct-- VectorBuilder Inc. - en global ledare inom genleveransteknik - meddelade att deras FoU- och tillverkningscenter i Guangzhou vann mästerskapet i sjunde globala tävlingen i innovation och företagande, som hölls i "Chuangke" Hangzhou, Kina. Denna inflytelserika och mycket konkurrensdrivna tävling är en av de största i Kina och täcker företag i tillväxtstadiet inom alla ...
moredpa Deutsche Presse-Agentur GmbH
Fact-checkers in Germany and Austria launch alliance against disinformation
moreFraunhofer-Institut für Sichere Informationstechnologie SIT
Document protection with colorful barcode / Simple forgery protection for paper documents and PDFs – automated tamper control via app
moreFraunhofer-Institut für Sichere Informationstechnologie SIT
Mechanism for Internet security broken
moreEuropean Society for Medical Oncology (ESMO)
ESMO 2022 - Great oaks grow from small acorns: oncology is committed to doing its part for sustainability
Paris (ots) - At ESMO 2022, 9-13 September, Paris, France, the premier cancer congress in Europe, which has gathered 28k participants from 167 countries, many discussions will be around sustainability, prevention and novel approaches which could soon become a reality in the clinic. - Late-breaking results elucidate ...
more